Skip to main content

Advertisement

Log in

Synthesis of novel 5-chloro-2-(thiophen-2-yl)-7,8-dihydroquinoline-6-carboxamides as potent inhibitors of Mycobacterium tuberculosis

  • Original Paper
  • Published:
Monatshefte für Chemie - Chemical Monthly Aims and scope Submit manuscript

Abstract

A series of novel 5-chloro-2-(thiophen-2-yl)-7,8-dihydroquinoline-6-carboxamides was designed, synthesized, and evaluated for antitubercular activity. The required 5-chloro-2-(thiophen-2-yl)-7,8-dihydroquinoline-6-carboxylic acid intermediate was prepared by oxidizing the respective aldehyde with sodium chlorite and 30% H2O2. Further, the acid was coupled with various aryl, alkyl, and heterocyclic amines using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and hydroxybenzotriazole to give the desired 5-chloro-2-(thiophen-2-yl)-7,8-dihydroquinoline-6-carboxamides in excellent yields. All the new compounds were characterized by their NMR and mass spectral analysis. Screening of all new compounds for in vitro antimycobacterial activity against M. tuberculosis H37Rv (Mtb) resulted in five analogs with MIC 3.12 µg/cm3 as promising antitubercular agents with lower cytotoxicity profiles.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. TB India 2017-Annual status report. https://www.tbfacts.org/wp-content/uploads/2017/12/TB-India-2017.pdf

  2. Prasad R, Singh A, Balasubramanian V, Gupta N (2017) Indian J Med Res 145:271

    PubMed  PubMed Central  Google Scholar 

  3. Hudson A, Imamura T, Gutteridge W, Kanyok T, Nunn P (2003) The current anti-TB drug research and development pipeline. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/68355

  4. Libardo MDJ, de la Fuente-Nuñez C, Anand K, Krishnamoorthy G, Kaiser P, Pringle SC, Dietz C, Pierce S, Smith MB, Barczak A, Kaufmann SH (2018) ACS Infect Dis 4:1623

    Article  CAS  Google Scholar 

  5. Tong AS, Choi PJ, Blaser A, Sutherland HS, Tsang SK, Guillemont J, Motte M, Cooper CB, Andries K, Van den Broeck W, Franzblau SG (2017) ACS Med Chem Lett 8:1019

    Article  CAS  Google Scholar 

  6. Duan S, Huang S, Gong J, Shen Y, Zeng L, Feng Y, Ren W, Leng Y, Hu Y (2015) ACS Med Chem Lett 6:386

    Article  CAS  Google Scholar 

  7. Viegas-Junior C, Danuello A, da Silva Bolzani V, Barreiro EJ, Fraga CAM (2007) Curr Med Chem 14:1829

    Article  CAS  Google Scholar 

  8. Bérubé G (2016) Exp Opin Drug Dis 11:281

    Article  Google Scholar 

  9. Marvadi SK, Krishna VS, Sriram D, Kantevari S (2019) Eur J Med Chem 164:171

    Article  CAS  Google Scholar 

  10. Marvadi SK, Krishna VS, Sriram D, Kantevari S (2019) Bioorg Med Chem Lett 29:529

    Article  CAS  Google Scholar 

  11. Marvadi SK, Krishna VS, Sinegubova EO, Volobueva AS, Esaulkova YL, Muryleva AA, Tentler DG, Sriram D, Zarubaev VV, Kantevari S (2019) Bioorg Med Chem Lett 29:2664

    Article  CAS  Google Scholar 

  12. Kantevari S, Patpi SR, Addla D, Putapatri SR, Sridhar B, Yogeeswari P, Sriram D (2011) ACS Comb Sci 13:427

    Article  CAS  Google Scholar 

  13. Kantevari S, Patpi SR, Sridhar B, Yogeeswari P, Sriram D (2011) Bioorg Med Chem Lett 21:1214

    Article  CAS  Google Scholar 

  14. Pulipati L, Sridevi JP, Yogeeswari P, Sriram D, Kantevari S (2016) Bioorg Med Chem Lett 26:3135

    Article  CAS  Google Scholar 

  15. Surineni G, Marvadi SK, Yogeeswari P, Sriram D, Kantevari S (2018) Bioorg Med Chem Lett 28:1610

    Article  CAS  Google Scholar 

  16. Surineni G, Yogeeswari P, Sriram D, Kantevari S (2015) Bioorg Med Chem Lett 25:485

    Article  CAS  Google Scholar 

  17. Kantevari S, Yempala T, Surineni G, Sridhar B, Yogeeswari P, Sriram D (2011) Eur J Med Chem 46:4827

    Article  CAS  Google Scholar 

  18. Patpi SR, Pulipati L, Yogeeswari P, Sriram D, Jain N, Sridhar B, Murthy R, Anjana Devi T, Kalivendi SV, Kantevari S (2012) J Med Chem 55:3911

    Article  CAS  Google Scholar 

  19. Reck F, Alm R, Brassil P, Newman J, DeJonge B, Eyermann CJ, Breault G, Breen J, Comita-Prevoir J, Cronin M, Davis H (2011) J Med Chem 54:7834

    Article  CAS  Google Scholar 

  20. Biava M, Porretta GC, Poce G, Supino S, Deidda D, Pompei R, Molicotti P, Manetti F, Botta M (2006) J Med Chem 49:4946

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors thank Indo-Russia DST-RFBR collaborative project (INT/RUS/RFBR/P-296) for financial support. SKM is thankful to UGC for senior research fellowship. CSIR-IICT communication no. IICT/Pubs./2019/045.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Srinivas Kantevari.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 4217 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marvadi, S.K., Nagineni, D., Safoora, S. et al. Synthesis of novel 5-chloro-2-(thiophen-2-yl)-7,8-dihydroquinoline-6-carboxamides as potent inhibitors of Mycobacterium tuberculosis. Monatsh Chem 151, 405–415 (2020). https://doi.org/10.1007/s00706-020-02560-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00706-020-02560-2

Keywords

Navigation